Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Syncom Formulations (India) Limited (SYNCOMF) total market value for the company's overall valuation and market capitalisation.
Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency. Explore how high is Syncom Formulations (India) Limited's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Capstone Energy Plus, Inc. Common Stock
NASDAQ:CEPL
|
0.182x |
|
Inscobee
KO:006490
|
0.020x |
|
ST.GEORGE MINING LTD
F:S0G
|
N/A |
|
Avita Medical Inc
AU:AVH
|
0.411x |
|
In The F
KO:014990
|
0.009x |
|
Gulf Island Fabrication Inc
NASDAQ:GIFI
|
0.030x |
|
Iron Force Industrial Co Ltd
TW:2228
|
0.080x |
|
SOL-GEL TECHN. IS-10
F:4SG
|
N/A |
Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. View Syncom Formulations (India) Limited share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs3.42 Billion ≈ $37.00 Million |
Rs234.36 Million ≈ $2.53 Million |
0.068x | +430.29% |
| 2024-03-31 | Rs2.87 Billion ≈ $31.07 Million |
Rs-59.58 Million ≈ $-644.37K |
-0.021x | -150.42% |
| 2023-03-31 | Rs2.56 Billion ≈ $27.69 Million |
Rs105.29 Million ≈ $1.14 Million |
0.041x | -44.03% |
| 2022-03-31 | Rs2.22 Billion ≈ $24.03 Million |
Rs163.29 Million ≈ $1.77 Million |
0.073x | +791.44% |
| 2021-03-31 | Rs1.88 Billion ≈ $20.29 Million |
Rs-19.93 Million ≈ $-215.59K |
-0.011x | -206.10% |
| 2020-03-31 | Rs1.46 Billion ≈ $15.75 Million |
Rs-5.06 Million ≈ $-54.69K |
-0.003x | -110.64% |
| 2019-03-31 | Rs1.33 Billion ≈ $14.34 Million |
Rs43.29 Million ≈ $468.17K |
0.033x | +348.68% |
| 2018-03-31 | Rs1.22 Billion ≈ $13.19 Million |
Rs-16.01 Million ≈ $-173.10K |
-0.013x | -111.13% |
| 2017-03-31 | Rs1.17 Billion ≈ $12.69 Million |
Rs138.41 Million ≈ $1.50 Million |
0.118x | -46.97% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.76 Million |
Rs241.74 Million ≈ $2.61 Million |
0.222x | +11832.06% |
| 2015-03-31 | Rs1.00 Billion ≈ $10.84 Million |
Rs1.87 Million ≈ $20.20K |
0.002x | -97.36% |
| 2014-03-31 | Rs951.99 Million ≈ $10.30 Million |
Rs67.30 Million ≈ $727.87K |
0.071x | +7.30% |
| 2013-03-31 | Rs877.09 Million ≈ $9.49 Million |
Rs57.79 Million ≈ $624.96K |
0.066x | -14.20% |
| 2012-03-31 | Rs836.08 Million ≈ $9.04 Million |
Rs64.20 Million ≈ $694.33K |
0.077x | +281.55% |
| 2011-03-31 | Rs816.58 Million ≈ $8.83 Million |
Rs-34.54 Million ≈ $-373.52K |
-0.042x | -381.24% |
| 2010-03-31 | Rs550.47 Million ≈ $5.95 Million |
Rs-4.84 Million ≈ $-52.32K |
-0.009x | +51.59% |
| 2009-03-31 | Rs411.32 Million ≈ $4.45 Million |
Rs-7.47 Million ≈ $-80.76K |
-0.018x | -112.90% |
| 2008-03-31 | Rs390.34 Million ≈ $4.22 Million |
Rs54.94 Million ≈ $594.11K |
0.141x | -0.43% |
| 2007-03-31 | Rs342.37 Million ≈ $3.70 Million |
Rs48.40 Million ≈ $523.37K |
0.141x | +69.71% |
| 2006-03-31 | Rs292.59 Million ≈ $3.16 Million |
Rs24.37 Million ≈ $263.55K |
0.083x | -- |
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more